CEOs Face Grilling On Vaccine Supply In EU
European Parliament To Also Cross-Examine European Commission
Executive Summary
AstraZeneca's CEO and other leaders from COVID-19 vaccine companies will face some tough questions in Brussels, but the European Commission wants to put differences behind it and solve the vaccine supply problem as soon as possible.
You may also be interested in...
Stung By COVID Critics, EU Looks To BARDA-Style Agency To Act Faster On Variants
The European Commission wants to learn from mistakes made in the COVID-19 crisis and to create an end-to-end system to co-ordinate funding, clinical research and manufacturing of vaccines.
EU Backs Down In Row Over AstraZeneca Vaccine Supplies
The European Commission has averted all-out conflict with AstraZeneca and the UK government, with good news from J&J and Pfizer/BioNTech easing supply concerns.
Investor Faith In David Hung’s Nuvation Renewed By Anheart Buyout
The acquisition brings two potential best-in-class cancer therapies, which could make Nuvation a commercial company as soon as 2025.